Market Analysis - Unibest Industrial Co., Ltd.

Blogs

Welcome to Unibest's Blogs section! Here, you will find valuable insights and in-depth reports covering various topics related to drugs and diseases. Our blogs aim to provide an enhanced understanding of the clinical significance and breakthroughs your clients can make. Stay updated with the latest trends, technological advancements, and industry analyses as we dive deep into the world of pharmaceuticals, giving you the knowledge and resources you need to stay ahead of the competition.

Avacopan - Orphan Drug with a Growing Market
2024-06-07

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA-associated vasculitis) is a rare but serious autoimmune disease affecting small blood vessels. With a global prevalence estimated between 30-218 cases per million, it leads to inflammation of blood vessels and potential organ damage. C Read More
Opportunities for API Manufacturers in the Expanding Ruxolitinib Market
2024-05-15

Ruxolitinib, a groundbreaking product of Incyte Corp, has demonstrated an impressive evolution in the pharmaceutical market. Its strategic journey from a niche treatment for rare diseases to a versatile solution for more common dermatological conditions not only emphasizes the strategic significance Read More
Seizing the Opportunity in the CGRP Targeting Drugs Market
2024-02-04

The global pharmaceutical landscape is witnessing a remarkable surge in the development and approval of drugs targeting trigeminal neuropeptide calcitonin gene-related peptide (CGRP) or its receptor, especially for treating migraine, a debilitating neurological disorder affecting a substantial adult Read More
Market Analysis of Vibegron for the Treatment of Overactive Bladder
2024-01-02

Prevalence of OABAccording to Statistic Brain, an estimated 183 million people worldwide suffer from overactive bladder (OAB), with North America having the highest prevalence. In the U.S. alone, around 66.6 million people experience OAB symptoms, suggesting a significant market potential for OAB tr Read More
Overactive Bladder: An Overview for Global Drug Company BDs And VPs
2023-12-01

Overactive Bladder (OAB) is a common urological condition, with significant impacts on patients' quality of life and substantial economic implications for the healthcare market. For stakeholders in the pharmaceutical industry - particularly those targeting the urology market - it's crucial to unders Read More
The overlooked opportunity in heart health: Generic EPA
2023-11-30

Heart disease continues to be the primary cause of death globally, claiming upwards of 17 million lives each year. Statins have evolved as an acceptable course for reducing LDL cholesterol and cardiovascular risk. Yet, a significant residual risk remains. With the increasing prevalence of obesity, d Read More
The Growing Global Burden of Diabetes
2023-11-13

November 14th marks World Diabetes Day, a day to raise awareness of the impact of diabetes globally. This year's theme is "Access to Diabetes", focusing on the importance of knowing your risk for type 2 diabetes and ensuring access to proper information and care. In honor of World Diabetes Day 2023, Read More
Forecasting the Global Demand for Ubrogepant
2023-10-19

In the dynamic realm of the pharmaceutical industry, where the drive for improved patient outcomes meets the reality of a global market, understanding and forecasting demand is key. Unibest has developed a step-by-step approach to calculating the market potential for specific pharmaceuticals. In thi Read More
The Chronic Impact of Migraine: The Need for New Treatment Options
2023-10-18

Migraine is a highly prevalent and disabling neurological disease, affecting approximately 12% of adults worldwide. For those living with migraines, the condition can severely impact their quality of life and ability to function. Migraine attacks involve moderate to severe throbbing head pain, often Read More